Percutaneous Coronary Interventions in Cardiac Allograft Vasculopathy: A Single-Center Experience

Transplantation Proceedings

Volumn 42, Issue 4, 2010, Pages 1286-1290

  Colombo, P ^a   Bruschi, G ^a   Sacco, A ^a   Oreglia, J ^a   De Marco, F ^a   Colombo, T ^a   Botta, L ^a   Macera, F ^a   Turazza, F ^a   Frigerio, M ^a   Martinelli, L ^a   Klugmann, S ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CARDIAC ALLOGRAFT VASCULOPATHY; CORONARY STENT; DISEASE COURSE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RECURRENT DISEASE; RETRANSPLANTATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANGIOPLASTY, BALLOON, CORONARY; BIOPSY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DRUG THERAPY, COMBINATION; FEMALE; HEART CATHETERIZATION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PALLIATIVE CARE; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; VASCULAR DISEASES;

EID: 77952573045     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.03.065     Document Type: Article

References (26)

1. Costanzo M.R., Naftel D.C., Pritzker M.R., et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. J Heart Lung Transplant 17 (1998) 744
2. Keogh A.M., Valantine H.A., Hunt S.A., et al. Impact of proximal or mid-vessel discreet coronary artery stenoses on survival after heart transplantation. J Heart Lung Transplant 11 (1992) 892
3. Kobashigawa J.A. Coronary artery disease in the transplanted heart: why does it happen and what can we do about it?. Cardiol Rev 4 (1996) 1
4. Ramzy D., Rao V., Brahm J., et al. Cardiac allograft vasculopathy: a review. Can J Surg 48 (2005) 319
5. Avery R.K. Cardiac-allograft vasculopathy. N Engl J Med 349 (2003) 829
6. Halle III A.A., DiSciacio G., Massin E.K., et al. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol 26 (1995) 120
7. Eisen H.J., Tuzcu E.M., Dorent R., et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349 (2003) 847
8. Frigerio M., Garascia A., Roubina E., et al. Cardiac allograft vasculopathy: differences in de novo and maintenance heart transplant recipients. Transplantation 82 (2006) S5
9. Heublein B., Pethig K., Maas C., et al. Coronary artery stenting in cardiac allograft vascular disease. J Am Coll Cardiol 32 (1997) 1636
10. Jain S.P., Ramee S.R., White C.J., et al. Coronary stenting in cardiac allograft vasculopathy. J Am Coll Cardiol 32 (1998) 1636
11. Swan J.W., Norell M., Yacoub M., et al. Coronary angioplasty in cardiac transplant recipients. Eur Heart J 14 (1993) 65
12. Von Scheidt W., Uberfuhr P., Reichart B., et al. The role of PTCA in the management of focal critical lesions in transplant coronary artery disease. Transplant Proc 27 (1995) 1936
13. Schnetzler B., Drobinski G., Dorent R., et al. The role of percutaneous transluminal coronary angioplasty in heart transplant recipients. J Heart Lung Transplant 19 (2000) 557
14. Aranda J.M., Pauly D.F., Kerensky R.A., et al. Percutaneous coronary intervention versus medical therapy for coronary allograft vasculopathy. One center's experience. J Heart Lung Transplant 21 (2002) 860
15. Gao S.Z., Alderman E.L., Schroeder J.S., et al. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol 12 (1988) 334
16. Sullivan D.R., Marwick T., and Freedman S. A new method of scoring coronary angiograms to reflect etent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 119 (1990) 1262
17. Kobashigawa J.A., Tobis J.M., Starling R.C., et al. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol 45 (2005) 1532
18. Schroeder J.S., and Hunt S.A. Chest pain in heart transplant recipients. N Engl J Med 324 (1991) 1805
19. Wong P.M., Piamsomboon C., Mathur A., et al. Efficacy of coronary stenting in the management of cardiac allograft vasculopathy. Am J Cardiol 82 (1988) 239
20. Redonnet M., Tron C., Koning R., et al. Coronary angioplasty and stenting in cardiac allograft vasculopathy following heart transplantation. Transplant Proc 32 (2000) 463
21. Simpson L., Lee E., Hott B., et al. Long-term results of angioplasty vs stenting in cardiac transplant recipients with allograft vasculopathy. J Heart Lung Transplant 24 (2005) 1211
22. Meiser B.M., Billingham M.E., and Morris R.E. Effects of cyclosporine, FK506, and rapamycin on graft-vessel disease. Lancet 338 (1991) 1297
23. Schuler W., Sedrani R., Cottens S., et al. SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo. Transplantation 64 (1997) 36
24. Eisen H., Tuzcu E., Dorent R., et al., RAD B253 Study Group. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349 (2003) 9
25. Moses J.W., Leon M.B., Popma J.J., et al., SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315
26. Stone G.W., Ellis S.G., Cox D.A., et al., TAXUS-IV Investigators. One-year clinical results with the slow-release, polymer-based, paclitaxeleluting TAXUS stent: the TAXUS-IV trial. Circulation 109 (2004) 1942